Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fsd Pharma Inc Cl B (CSE: HUGE )

1.160 +0.010 (+0.87%)
Streaming Delayed Price Updated: 12:11 PM EDT, May 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,844
Open 1.150
Bid (Size) 1.160 (15,400)
Ask (Size) 1.170 (600)
Prev. Close 1.150
Today's Range 1.150 - 1.180
52wk Range 1.010 - 2.660
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Featured in InvestmentPitch Media Video
Via Investor Brand Network
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Closes CAD$16.4M Sale of Non-Core Assets
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis

Performance

YTD
-16.55%
-16.55%
1 Month
-12.12%
-12.12%
3 Month
+10.48%
+10.48%
6 Month
-40.82%
-40.82%
1 Year
-44.23%
-44.23%

More News

Read More
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
From FSD Pharma Inc.
Via Business Wire
FSD Pharma Announces Dismissal of Derivative Complaint
From FSD Pharma Inc.
Via Business Wire
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Partners with Tekkfund Capital, Issues Shares for Services
Via Investor Brand Network
FSD Pharma Announces Engagement with Tekkfund Capital and Share Issuance to Crystal Research Associates
From FSD Pharma Inc.
Via Business Wire
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Strategic Advisory Board Appointments
Via Investor Brand Network
FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board
From FSD Pharma Inc.
Via Business Wire
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari
From FSD Pharma Inc.
Via Business Wire
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Shares Update on Corporate Activity
Via Investor Brand Network
FSD Pharma Issues Corporate Updates
From FSD Pharma Inc.
Via Business Wire
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) Announces Filing of Year-End 2021 Results
Via Investor Brand Network
FSD Pharma Announces Filing of Year-End 2021 Results
From FSD Pharma Inc.
Via Business Wire
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Spotlighted in Recent EIO Report from Crystal Research Associates
Via Investor Brand Network
FSD Pharma Announces Executive Informational Overview Report Produced by Crystal Research Associates LLC
From FSD Pharma Inc.
Via Business Wire
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Enters Agreement for Sale of Cobourg Facility for CAD$16.5M
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
FSD Pharma Announces Agreement for Sale of Cobourg Facility for CAD$16,500,000
From FSD Pharma Inc.
Via Business Wire
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) Unveils Newly Designed Website
Via Investor Brand Network
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) Unveils Newly Designed Corporate Website
Via Investor Brand Network
FSD Pharma Announces Launch of New Corporate Website
From FSD Pharma Inc.
Via Business Wire
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) Board Member Named to the Order of Canada
Via Investor Brand Network
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Board Member Named to the Order of Canada
Via Investor Brand Network
FSD Pharma Congratulates Dr. Eleanor Fish on Being Named to the Order of Canada
From FSD Pharma Inc.
Via Business Wire
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Participation in Upcoming H.C. Wainwright Bioconnect Conference
Via Investor Brand Network
FSD Pharma to Present at the H.C. Wainwright Bioconnect Conference on January 10-13th
From FSD Pharma Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.